![Rikin Mehta](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Rikin Mehta is the founder of Lactiga, Inc. He is currently working as a Director at Licentiam, Inc.
Postes actifs de Rikin Mehta
Sociétés | Poste | Début |
---|---|---|
Licentiam, Inc.
![]() Licentiam, Inc. Information Technology ServicesTechnology Services Licentiam, Inc. provides information technology services. The firm engages in transforming the fragmented health and medical regulatory environment into a dynamic and integrated network, connecting practitioners and licensing boards, enabling portability and telehealth. The company was founded by Mark Vargas and Jason Reed and is headquartered in Woodbridge, NJ. | Directeur/Membre du Conseil | - |
Lactiga, Inc.
![]() Lactiga, Inc. BiotechnologyHealth Technology Lactiga, Inc. operates as bio Therapeutics Company, which develops biologic to prevent mucosal infections. Its product, LCTG-001, is designed for patients with Primary Immunodeficiency Diseases (PID), including Selective IgA Deficiency (SIgAD) and Common Variable Immunodeficiency (CVID). The company was founded by Viraj Mane and Rikin Mehta and is headquartered in Toronto, Canada. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Licentiam, Inc.
![]() Licentiam, Inc. Information Technology ServicesTechnology Services Licentiam, Inc. provides information technology services. The firm engages in transforming the fragmented health and medical regulatory environment into a dynamic and integrated network, connecting practitioners and licensing boards, enabling portability and telehealth. The company was founded by Mark Vargas and Jason Reed and is headquartered in Woodbridge, NJ. | Technology Services |
Lactiga, Inc.
![]() Lactiga, Inc. BiotechnologyHealth Technology Lactiga, Inc. operates as bio Therapeutics Company, which develops biologic to prevent mucosal infections. Its product, LCTG-001, is designed for patients with Primary Immunodeficiency Diseases (PID), including Selective IgA Deficiency (SIgAD) and Common Variable Immunodeficiency (CVID). The company was founded by Viraj Mane and Rikin Mehta and is headquartered in Toronto, Canada. | Health Technology |